
    
      General Purpose

      1. To comparatively evaluate the tolerability and efficacy of a fixed combination of
      furosemide (40 mg) and amiloride (10 mg) compared with furosemide alone, in the treatment of
      patients with HF functional class II (NYHA)

      Specific Purposes

        1. To evaluate the effect on kalemia of the fixed combination of furosemide and amiloride
           compared with furosemide alone in the treatment of patients with HF functional class II
           (NYHA)

        2. To evaluate the efficacy of the fixed combination of furosemide and amiloride in
           reducing edema of the LLLL, as compared with furosemide alone, in the treatment of
           patients with HF functional class II (NYHA).
    
  